University of Namibia

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Chronic Disease, Disease Attributes, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bacterial infectious disease, chronic obstructive pulmonary disease, gram-positive bacterial infections, lung disorder, mycobacterial infectious disease, obstructive lung disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis	Recruiting	Phase 2 / Phase 3	2024-08-23		NCT04147286

Clinical trials